BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kutsumi H, Inokuchi H, Serhan CN, Blumberg RS, Azuma T. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 2010;16:87-95. [PMID: 19572372 DOI: 10.1002/ibd.21029] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res. 2012;51:232-237. [PMID: 22542696 DOI: 10.1016/j.plipres.2012.02.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 10.0] [Reference Citation Analysis]
2 Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 Fatty Acid-Derived Mediators 17( R )-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice. J I 2011;187:1957-69. [DOI: 10.4049/jimmunol.1101305] [Cited by in Crossref: 168] [Cited by in F6Publishing: 163] [Article Influence: 15.3] [Reference Citation Analysis]
3 Sima C, Montero E, Nguyen D, Freire M, Norris P, Serhan CN, Van Dyke TE. ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance. Sci Rep 2017;7:12848. [PMID: 28993702 DOI: 10.1038/s41598-017-13185-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
4 Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 2011;437:185-97. [PMID: 21711247 DOI: 10.1042/BJ20110327] [Cited by in Crossref: 99] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
5 Kikut J, Drozd A, Mokrzycka M, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Are EPA and DHA Derivatives Involved in IBD Remission? JCM 2022;11:2388. [DOI: 10.3390/jcm11092388] [Reference Citation Analysis]
6 Ungaro F, Tacconi C, Massimino L, Corsetto PA, Correale C, Fonteyne P, Piontini A, Garzarelli V, Calcaterra F, Della Bella S, Spinelli A, Carvello M, Rizzo AM, Vetrano S, Petti L, Fiorino G, Furfaro F, Mavilio D, Maddipati KR, Malesci A, Peyrin-Biroulet L, D'Alessio S, Danese S. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. Gastroenterology 2017;153:1363-1377.e6. [PMID: 28827082 DOI: 10.1053/j.gastro.2017.07.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
7 Marrone MC, Coccurello R. Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases. Biomolecules 2019;10:E12. [PMID: 31861745 DOI: 10.3390/biom10010012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Dranse HJ, Rourke JL, Stadnyk AW, Sinal CJ. Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitis. Physiol Rep 2015;3:e12497. [PMID: 26265756 DOI: 10.14814/phy2.12497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
9 Furumatsu K, Nishiumi S, Kawano Y, Ooi M, Yoshie T, Shiomi Y, Kutsumi H, Ashida H, Fujii-Kuriyama Y, Azuma T. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci. 2011;56:2532-2544. [PMID: 21374063 DOI: 10.1007/s10620-011-1643-9] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 8.5] [Reference Citation Analysis]
10 Weir TL, Trikha SRJ, Thompson HJ. Diet and cancer risk reduction: The role of diet-microbiota interactions and microbial metabolites. Semin Cancer Biol 2021;70:53-60. [PMID: 32574813 DOI: 10.1016/j.semcancer.2020.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Chamani S, Bianconi V, Tasbandi A, Pirro M, Barreto GE, Jamialahmadi T, Sahebkar A. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins. Mediators Inflamm 2020;2020:3267172. [PMID: 32308554 DOI: 10.1155/2020/3267172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922-43. [PMID: 21766791 DOI: 10.1021/cr100396c] [Cited by in Crossref: 607] [Cited by in F6Publishing: 560] [Article Influence: 55.2] [Reference Citation Analysis]
13 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
14 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Saika A, Nagatake T, Kunisawa J. Host- and Microbe-Dependent Dietary Lipid Metabolism in the Control of Allergy, Inflammation, and Immunity. Front Nutr 2019;6:36. [PMID: 31024921 DOI: 10.3389/fnut.2019.00036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
16 Zhao Q, Wu J, Lin Z, Hua Q, Zhang W, Ye L, Wu G, Du J, Xia J, Chu M, Hu X. Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. Inflammation 2016;39:1319-33. [PMID: 27145782 DOI: 10.1007/s10753-016-0364-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
17 Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther. 2010;332:541-548. [PMID: 19846590 DOI: 10.1124/jpet.109.159046] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
18 Shen W, Gaskins HR, McIntosh MK. Influence of dietary fat on intestinal microbes, inflammation, barrier function and metabolic outcomes. J Nutr Biochem. 2014;25:270-280. [PMID: 24355793 DOI: 10.1016/j.jnutbio.2013.09.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 9.9] [Reference Citation Analysis]
19 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
20 Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition 2011;27:733-44. [PMID: 21454053 DOI: 10.1016/j.nut.2010.12.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
21 Blaudez F, Ivanovski S, Fournier B, Vaquette C. The utilisation of resolvins in medicine and tissue engineering. Acta Biomater 2021:S1742-7061(21)00803-5. [PMID: 34875358 DOI: 10.1016/j.actbio.2021.11.047] [Reference Citation Analysis]
22 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic Biol Med. 2012;52:2013-2037. [PMID: 22391222 DOI: 10.1016/j.freeradbiomed.2012.02.035] [Cited by in Crossref: 162] [Cited by in F6Publishing: 144] [Article Influence: 16.2] [Reference Citation Analysis]
24 Avila-Román J, Talero E, Alcaide A, Reyes Cde L, Zubía E, García-Mauriño S, Motilva V. Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats. Br J Nutr 2014;112:1055-64. [PMID: 25192306 DOI: 10.1017/S0007114514001895] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities. Front Immunol 2021;12:702785. [PMID: 34276698 DOI: 10.3389/fimmu.2021.702785] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Dubé L, Spahis S, Lachaîne K, Lemieux A, Monhem H, Poulin S, Randoll C, Travaillaud E, Ould-chikh N, Marcil V, Delvin E, Levy E. SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0156] [Reference Citation Analysis]
27 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
28 Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of Resolvins in the Inflammatory Resolution of Neurological Diseases. Front Pharmacol 2020;11:612. [PMID: 32457616 DOI: 10.3389/fphar.2020.00612] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
29 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lee H, Surh Y. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochemical Pharmacology 2012;84:1340-50. [DOI: 10.1016/j.bcp.2012.08.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
31 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Weylandt KH. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell. Eur J Pharmacol 2016;785:108-15. [PMID: 26546723 DOI: 10.1016/j.ejphar.2015.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
33 Weylandt KH, Chiu C, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators 2012;97:73-82. [DOI: 10.1016/j.prostaglandins.2012.01.005] [Cited by in Crossref: 173] [Cited by in F6Publishing: 156] [Article Influence: 17.3] [Reference Citation Analysis]
34 Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep 2017;19:57. [PMID: 29110146 DOI: 10.1007/s11883-017-0696-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
35 Wu D, Lewis ED, Pae M, Meydani SN. Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance. Front Immunol 2018;9:3160. [PMID: 30697214 DOI: 10.3389/fimmu.2018.03160] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 38.7] [Reference Citation Analysis]
36 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
37 Nagatake T, Kunisawa J. Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation. Int Immunol 2019;31:569-77. [PMID: 30722032 DOI: 10.1093/intimm/dxy086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
38 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
39 Roy J, Lefkimmiatis K, Moyer MP, Curci S, Hofer AM. The {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism. Am J Physiol Gastrointest Liver Physiol 2010;299:G715-22. [PMID: 20576916 DOI: 10.1152/ajpgi.00028.2010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
40 Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010;177:1576-91. [PMID: 20813960 DOI: 10.2353/ajpath.2010.100322] [Cited by in Crossref: 289] [Cited by in F6Publishing: 266] [Article Influence: 24.1] [Reference Citation Analysis]
41 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
42 Sawada Y, Saito-Sasaki N, Nakamura M. Omega 3 Fatty Acid and Skin Diseases. Front Immunol 2020;11:623052. [PMID: 33613558 DOI: 10.3389/fimmu.2020.623052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Zhang F, Yang H, Pan Z, Wang Z, Wolosin JM, Gjorstrup P, Reinach PS. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci 2010;51:5601-9. [PMID: 20538990 DOI: 10.1167/iovs.09-4468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
44 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
45 Quiros M, Feier D, Birkl D, Agarwal R, Zhou DW, García AJ, Parkos CA, Nusrat A. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc Natl Acad Sci U S A 2020;117:9477-82. [PMID: 32300016 DOI: 10.1073/pnas.1921335117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
46 Freire MO, Dalli J, Serhan CN, Van Dyke TE. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. J Immunol 2017;198:718-28. [PMID: 27994073 DOI: 10.4049/jimmunol.1601543] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
47 Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol. 2013;191:4288-4298. [PMID: 24038091 DOI: 10.4049/jimmunol.1202743] [Cited by in Crossref: 121] [Cited by in F6Publishing: 123] [Article Influence: 13.4] [Reference Citation Analysis]
48 Irún P, Lanas A, Piazuelo E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 2019;10:852. [PMID: 31427966 DOI: 10.3389/fphar.2019.00852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
49 Kaushal N, Kudva AK, Patterson AD, Chiaro C, Kennett MJ, Desai D, Amin S, Carlson BA, Cantorna MT, Prabhu KS. Crucial role of macrophage selenoproteins in experimental colitis. J Immunol. 2014;193:3683-3692. [PMID: 25187657 DOI: 10.4049/jimmunol.1400347] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
50 Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
51 Ho GT, Cartwright JA, Thompson EJ, Bain CC, Rossi AG. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing. Inflamm Bowel Dis 2020;26:1131-43. [PMID: 32232386 DOI: 10.1093/ibd/izaa045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
52 Doyle JR, Krishnaji ST, Zhu G, Xu ZZ, Heller D, Ji RR, Levy BD, Kumar K, Kopin AS. Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain. J Biol Chem 2014;289:13385-96. [PMID: 24659779 DOI: 10.1074/jbc.M113.522680] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
53 Shores DR, Binion DG, Freeman BA, Baker PR. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2192-204. [PMID: 21910181 DOI: 10.1002/ibd.21560] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
54 Lin N, Shay JES, Xie H, Lee DSM, Skuli N, Tang Q, Zhou Z, Azzam A, Meng H, Wang H, FitzGerald GA, Simon MC. Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis. Front Immunol 2018;9:2565. [PMID: 30455703 DOI: 10.3389/fimmu.2018.02565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
55 Kim TH, Kim GD, Jin YH, Park YS, Park CS. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Int Immunopharmacol 2012;14:384-91. [PMID: 22951188 DOI: 10.1016/j.intimp.2012.08.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
56 Headland SE, Norling LV. The resolution of inflammation: Principles and challenges. Semin Immunol 2015;27:149-60. [PMID: 25911383 DOI: 10.1016/j.smim.2015.03.014] [Cited by in Crossref: 191] [Cited by in F6Publishing: 175] [Article Influence: 27.3] [Reference Citation Analysis]
57 Xu H, Chen J, Ge J, Xia K, Tao S, Su Y, Zhang Q. Resolvin E1 Ameliorates Pulpitis by Suppressing Dental Pulp Fibroblast Activation in a Chemerin Receptor 23-dependent Manner. J Endod 2019;45:1126-1134.e1. [PMID: 31353056 DOI: 10.1016/j.joen.2019.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
58 Moreno JJ. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis. Eur J Pharmacol 2017;796:7-19. [PMID: 27940058 DOI: 10.1016/j.ejphar.2016.12.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
59 Dalli J, Serhan CN. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front Immunol 2017;8:1400. [PMID: 29163481 DOI: 10.3389/fimmu.2017.01400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
60 Becker F, Romero E, Goetzmann J, Hasselschwert DL, Dray B, Vanchiere J, Fontenot J, Yun JW, Norris PC, White L, Musso M, Serhan CN, Alexander JS, Gavins FNE. Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys. Am J Pathol 2019;189:1953-72. [PMID: 31547920 DOI: 10.1016/j.ajpath.2019.05.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
61 Hwang SM, Chung G, Kim YH, Park CK. The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration. Int J Mol Sci 2019;20:E5849. [PMID: 31766461 DOI: 10.3390/ijms20235849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
62 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
63 Imaizumi T, Kobayashi A, Otsubo S, Komai M, Magara M, Otsubo N. The discovery and optimization of a series of 2-aminobenzoxazole derivatives as ChemR23 inhibitors. Bioorganic & Medicinal Chemistry 2019;27:115091. [DOI: 10.1016/j.bmc.2019.115091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol 2016;785:156-64. [PMID: 26325092 DOI: 10.1016/j.ejphar.2015.08.050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
65 Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol 2011;186:1735-46. [PMID: 21187448 DOI: 10.4049/jimmunol.1003456] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
66 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
67 Lee HN, Na HK, Surh YJ. Resolution of inflammation as a novel chemopreventive strategy. Semin Immunopathol 2013;35:151-61. [PMID: 23370700 DOI: 10.1007/s00281-013-0363-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
68 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
69 Köhnke T, Gomolka B, Bilal S, Zhou X, Sun Y, Rothe M, Baumgart DC, Weylandt KH. Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators. Biomed Res Int. 2013;2013:748160. [PMID: 24083240 DOI: 10.1155/2013/748160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
70 Uddin M, Levy BD. Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 2011;50:75-88. [PMID: 20887750 DOI: 10.1016/j.plipres.2010.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
71 Panahi Y, Rajaee SM, Sahebkar A. Ocular Effects of Sulfur Mustard and Therapeutic Approaches. J Cell Biochem 2017;118:3549-60. [DOI: 10.1002/jcb.25892] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
72 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
73 Günay S, Taşova F, Yılmaz HE, Paköz ZB, Çekiç C. Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis. Gastroenterol Res Pract 2019;2019:6258327. [PMID: 30906319 DOI: 10.1155/2019/6258327] [Reference Citation Analysis]
74 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
75 Prevete N, Liotti F, Amoresano A, Pucci P, de Paulis A, Melillo RM. New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution. Pharmacological Research 2018;128:80-7. [DOI: 10.1016/j.phrs.2017.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
76 Buechler C. Chemerin, a novel player in inflammatory bowel disease. Cell Mol Immunol 2014;11:315-6. [PMID: 24705196 DOI: 10.1038/cmi.2014.14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
77 Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev. 2011;30:507-523. [PMID: 22015691 DOI: 10.1007/s10555-011-9311-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
78 Rohwer N, Chiu CY, Huang D, Smyl C, Rothe M, Rund KM, Helge Schebb N, Kühn H, Weylandt KH. Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid. FASEB J 2021;35:e21491. [PMID: 33710695 DOI: 10.1096/fj.202002340RR] [Reference Citation Analysis]
79 Nishiokada A, Miyoshi M, Fujiwara M, Aoyama-ishikawa M, Maeshige N, Takahashi M, Hamada Y, Usami Y, Honda M, Arita M, Usami M. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS. Clinical Nutrition 2015;34:685-93. [DOI: 10.1016/j.clnu.2014.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
80 Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 2015;71:341-9. [PMID: 25752887 DOI: 10.1007/s13105-015-0395-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
81 Flesher RP, Herbert C, Kumar RK. Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma. Clin Sci (Lond) 2014;126:805-14. [PMID: 24344649 DOI: 10.1042/CS20130623] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
82 Trilleaud C, Gauttier V, Biteau K, Girault I, Belarif L, Mary C, Pengam S, Teppaz G, Thepenier V, Danger R, Robert-Siegwald G, Néel M, Bruneau S, Glémain A, Néel A, Poupon A, Mosnier JF, Chêne G, Dubourdeau M, Blancho G, Vanhove B, Poirier N. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci Adv 2021;7:eabd1453. [PMID: 33811066 DOI: 10.1126/sciadv.abd1453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Ahluwalia K, Ebright B, Chow K, Dave P, Mead A, Poblete R, Louie SG, Asante I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022;12:333. [DOI: 10.3390/metabo12040333] [Reference Citation Analysis]
84 Zhang L, Jia M, Sun T. The roles of special proresolving mediators in pain relief. Reviews in the Neurosciences 2018;29:645-60. [DOI: 10.1515/revneuro-2017-0074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
85 Camba-Gómez M, Gualillo O, Conde-Aranda J. New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation. Int J Mol Sci 2021;22:2605. [PMID: 33807591 DOI: 10.3390/ijms22052605] [Reference Citation Analysis]
86 Chiu CY, Gomolka B, Dierkes C, Huang NR, Schroeder M, Purschke M, Manstein D, Dangi B, Weylandt KH. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm Res. 2012;61:967-976. [PMID: 22618200 DOI: 10.1007/s00011-012-0489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
87 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014;816:25-52. [PMID: 24818718 DOI: 10.1007/978-3-0348-0837-8_2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 12.0] [Reference Citation Analysis]
89 Renuka, Kumar S, Sharma B, Sharma P, Agnihotri N. n-3 PUFAs: an Elixir in Prevention of Colorectal Cancer. Curr Colorectal Cancer Rep 2015;11:141-9. [DOI: 10.1007/s11888-015-0268-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
90 Maskrey BH, Megson IL, Rossi AG, Whitfield PD. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis. Mol Nutr Food Res 2013;57:1390-400. [PMID: 23417926 DOI: 10.1002/mnfr.201200723] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
91 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
92 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
93 Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E, Thanasoula M, Burykina TI, Tekos F, Buha A, Nikitovic D, Kouretas D, Tsatsakis AM. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol 2020;143:111558. [PMID: 32640331 DOI: 10.1016/j.fct.2020.111558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
94 Kim B, Guaregua V, Chen X, Zhao C, Yeow W, Berg NK, Eltzschig HK, Yuan X. Characterization of a Murine Model System to Study MicroRNA-147 During Inflammatory Organ Injury. Inflammation 2021;44:1426-40. [PMID: 33566257 DOI: 10.1007/s10753-021-01427-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Sugihara K, Morhardt TL, Kamada N. The Role of Dietary Nutrients in Inflammatory Bowel Disease. Front Immunol 2018;9:3183. [PMID: 30697218 DOI: 10.3389/fimmu.2018.03183] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
96 Chen J, Shetty S, Zhang P, Gao R, Hu Y, Wang S, Li Z, Fu J. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. Toxicology and Applied Pharmacology 2014;277:118-23. [DOI: 10.1016/j.taap.2014.03.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
97 Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20:166-175. [PMID: 23974993 DOI: 10.1097/mib.0b013e3182a69dca] [Cited by in Crossref: 123] [Cited by in F6Publishing: 77] [Article Influence: 15.4] [Reference Citation Analysis]
98 Kuzumoto T, Tanigawa T, Higashimori A, Kitamura H, Nadatani Y, Otani K, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage. PLoS One 2021;16:e0250862. [PMID: 33945545 DOI: 10.1371/journal.pone.0250862] [Reference Citation Analysis]
99 Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33:657-670. [PMID: 21094463 DOI: 10.1016/j.immuni.2010.11.011] [Cited by in Crossref: 773] [Cited by in F6Publishing: 741] [Article Influence: 64.4] [Reference Citation Analysis]
100 Hamabata T, Nakamura T, Masuko S, Maeda S, Murata T. Production of lipid mediators across different disease stages of dextran sodium sulfate-induced colitis in mice. J Lipid Res 2018;59:586-95. [PMID: 29414763 DOI: 10.1194/jlr.M079095] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
101 Volpato M, Hull MA. Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer. Cancer Metastasis Rev 2018;37:545-55. [PMID: 29971573 DOI: 10.1007/s10555-018-9744-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
102 Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013;12:89. [PMID: 23767972 DOI: 10.1186/1476-511X-12-89] [Cited by in Crossref: 91] [Cited by in F6Publishing: 53] [Article Influence: 10.1] [Reference Citation Analysis]
103 Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, Kondo Y, Furumatsu K, Shiomi H, Kutsumi H. GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis. 2011;17:2261-2274. [PMID: 21287666 DOI: 10.1002/ibd.21616] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
104 N. Serhan C, Krishnamoorthy S, Recchiuti A, Chiang N. . CTMC 2011;11:629-47. [DOI: 10.2174/1568026611109060629] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
105 Tyagi A, Kumar U, Reddy S, Santosh VS, Mohammed SB, Ehtesham NZ, Ibrahim A. Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease. Br J Nutr 2012;108:1612-22. [PMID: 22243775 DOI: 10.1017/S0007114511007197] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
106 Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun. 2015;83:792-801. [PMID: 25486994 DOI: 10.1128/iai.02444-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 6.9] [Reference Citation Analysis]
107 Sung HH, Sinclair AJ, Huynh K, Smith AAT, Mellett NA, Meikle PJ, Su XQ. Krill Oil Has Different Effects on the Plasma Lipidome Compared with Fish Oil Following 30 Days of Supplementation in Healthy Women: A Randomized Controlled and Crossover Study. Nutrients 2020;12:E2804. [PMID: 32933153 DOI: 10.3390/nu12092804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Morin C, Blier PU, Fortin S. MAG-EPA reduces severity of DSS-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2016;310:G808-21. [PMID: 27012773 DOI: 10.1152/ajpgi.00136.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
109 Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
110 Halade GV, Black LM, Verma MK. Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. Biotechnol Adv 2018;36:935-53. [PMID: 29499340 DOI: 10.1016/j.biotechadv.2018.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
111 Lee J, Moraes-Vieira PM, Castoldi A, Aryal P, Yee EU, Vickers C, Parnas O, Donaldson CJ, Saghatelian A, Kahn BB. Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses. J Biol Chem 2016;291:22207-17. [PMID: 27573241 DOI: 10.1074/jbc.M115.703835] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
112 Corazza BJM, Martinho FC, Khoury RD, Toia CC, Orozco EIF, Prado RF, Machado FP, Valera MC. Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis. Int Endod J 2021;54:61-73. [PMID: 32896000 DOI: 10.1111/iej.13403] [Reference Citation Analysis]
113 Duarte LRF, Pinho V, Rezende BM, Teixeira MM. Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives. Biomolecules 2022;12:75. [DOI: 10.3390/biom12010075] [Reference Citation Analysis]
114 Chen CT, Liu Z, Bazinet RP. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study: Rapid loss of eicosapentaenoic acid from brain phospholipids. Journal of Neurochemistry 2011;116:363-73. [DOI: 10.1111/j.1471-4159.2010.07116.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]